A new initiative by the microprocessor giant Intel will help aspiring Israeli entrepreneurs make their ideas a reality. On Monday, the company announced that as part of the Intel Ingenuity Partner Program (IPP), Intel would let Israeli entrepreneurs tap into…
Crowdmii was founded by experienced Israeli businessmen and activists who are passionate about connecting Israel’s innovation to the world. According to Assaf Luxembourg, Crowdmii’s CEO and a known Israeli activist himself, “Crowdmii as just another crowdfunding platform is not our…
Each of us has, in our nose, about six million smell receptors of around four hundred different types. The distribution of these receptors varies from person to person – so much so that each person’s sense of smell may be…
Since 2007, 96 awards, worth $40,000 apiece, have been awarded by the Weizmann Institute of Science to young women from all over Israel who are headed for a career in science. This year, another 11 young women who have excelled…
MUV Interactive’s trailblazing Bird wearable will turn every surface into a touchable interactive screen through motion, touch and voice. Four years ago, investors rejected Rami Parham’s concept of a wearable device for interacting with one’s digital environment based on finger…
Samsung is founding a startup accelerator in its development center in the Yakum industrial park. Yossi Smoler, head of the Open Innovation Group at Samsung Electronics Israel R&D center in Yakum, and former director of the incubators program in the…
Teva Pharmaceutical Industries and Microchips Biotech, Inc. announced that they have entered into a partnership under which the companies will explore innovative ways to apply Microchips Biotech’s implantable drug delivery device to Teva’s portfolio of products with the goal of…
Ben-Gurion University of the Negev Researcher Dr. Claude Brodski and colleagues from the Max-Planck Institute of Psychiatry and Ludwig-Maximilian University of Munich in Germany have recently shown the embryonic origins of mood fluctuations and its implications for bipolar disorder in…
“Science leads you in directions you hadn’t thought of, and you have to navigate your way through it.” Assistant Professor Reut Shalgi returned from MIT to Israel thanks to the Technion, where she currently investigates regulatory mechanisms of protein synthesis…
Doctors and scientists want drug regulators and research funding agencies to consider medicines that delay ageing-related disease as legitimate drugs. Such treatments have a physiological basis, researchers say, and could extend a person’s healthy years by slowing down the processes…
